Johnson & Johnson reports strong first-quarter earnings driven by surging sales in its medical devices business, with total revenue in line with expectations. The company also increases its quarterly dividend and provides updates on acquisitions and legal matters, including ongoing talc-related liabilities. [ad_1] An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business…
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
